These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28204942)

  • 1. Molecular modeling in the age of clinical genomics, the enterprise of the next generation.
    Prokop JW; Lazar J; Crapitto G; Smith DC; Worthey EA; Jacob HJ
    J Mol Model; 2017 Mar; 23(3):75. PubMed ID: 28204942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
    Damgaard RB; Fiil BK; Speckmann C; Yabal M; zur Stadt U; Bekker-Jensen S; Jost PJ; Ehl S; Mailand N; Gyrd-Hansen M
    EMBO Mol Med; 2013 Aug; 5(8):1278-95. PubMed ID: 23818254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of XIAP Variants of Uncertain Significance in Paediatric Patients with Refractory Crohn's Disease.
    Chang I; Park S; Lee HJ; Kim I; Park S; Ahn MK; Lee J; Kang M; Baek IJ; Sung YH; Pack CG; Kang HJ; Lee K; Im HJ; Seo EJ; Kim KM; Yang SK; Song K; Oh SH
    J Crohns Colitis; 2021 Aug; 15(8):1291-1304. PubMed ID: 33460440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
    Damgaard RB; Nachbur U; Yabal M; Wong WW; Fiil BK; Kastirr M; Rieser E; Rickard JA; Bankovacki A; Peschel C; Ruland J; Bekker-Jensen S; Mailand N; Kaufmann T; Strasser A; Walczak H; Silke J; Jost PJ; Gyrd-Hansen M
    Mol Cell; 2012 Jun; 46(6):746-58. PubMed ID: 22607974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
    Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
    Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.
    Amininejad L; Charloteaux B; Theatre E; Liefferinckx C; Dmitrieva J; Hayard P; Muls V; Maisin JM; Schapira M; Ghislain JM; Closset P; Talib M; Abramowicz M; Momozawa Y; Deffontaine V; Crins F; Mni M; Karim L; Cambisano N; Ornemese S; Zucchi A; Minsart C; Deviere J; Hugot JP; De Vos M; Louis E; Vermeire S; Van Gossum A; Coppieters W; Twizere JC; Georges M; Franchimont D;
    Gastroenterology; 2018 Jun; 154(8):2165-2177. PubMed ID: 29501442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
    Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
    J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
    Aguilar C; Lenoir C; Lambert N; Bègue B; Brousse N; Canioni D; Berrebi D; Roy M; Gérart S; Chapel H; Schwerd T; Siproudhis L; Schäppi M; Al-Ahmari A; Mori M; Yamaide A; Galicier L; Neven B; Routes J; Uhlig HH; Koletzko S; Patel S; Kanegane H; Picard C; Fischer A; Bensussan NC; Ruemmele F; Hugot JP; Latour S
    J Allergy Clin Immunol; 2014 Nov; 134(5):1131-41.e9. PubMed ID: 24942515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient pockets on XIAP-BIR2: toward the characterization of putative binding sites of small-molecule XIAP inhibitors.
    Eyrisch S; Medina-Franco JL; Helms V
    J Mol Model; 2012 May; 18(5):2031-42. PubMed ID: 21877153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.
    Ling B; Dong L; Zhang R; Wang Z; Liu Y; Liu C
    J Mol Graph Model; 2010 Nov; 29(3):354-62. PubMed ID: 20980180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
    Potenza D; Belvisi L; Vasile F; Moroni E; Cossu F; Seneci P
    Org Biomol Chem; 2012 Apr; 10(16):3278-87. PubMed ID: 22407164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the Apoptosis Pathway through Evolutionary Protein Design.
    Shultis D; Mitra P; Huang X; Johnson J; Khattak NA; Gray F; Piper C; Czajka J; Hansen L; Wan B; Chinnaswamy K; Liu L; Wang M; Pan J; Stuckey J; Cierpicki T; Borchers CH; Wang S; Lei M; Zhang Y
    J Mol Biol; 2019 Feb; 431(4):825-841. PubMed ID: 30625288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
    Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
    J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interactions between nucleotide binding domains and membrane spanning domains in cystic fibrosis transmembrane regulator: A molecular dynamic study.
    Belmonte L; Moran O
    Biochimie; 2015 Apr; 111():19-29. PubMed ID: 25640670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrity of XIAP is essential for effective activity recovery of apoptosome and its downstream caspases by Smac/Diablo.
    Attaran-Bandarabadi F; Abhari BA; Neishabouri SH; Davoodi J
    Int J Biol Macromol; 2017 Aug; 101():283-289. PubMed ID: 28322955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.